Covered recipient · General Payments record
CARLOS GAIBOR
General Payments · PY2024
$572.42
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $572.42 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $401.92 | 10 |
| CHIESI USA, INC. | $65.40 | 2 |
| Grifols USA, LLC | $43.14 | 3 |
| La Jolla Pharmaceutical Company | $28.13 | 1 |
| Kiniksa Pharmaceuticals International, plc | $18.87 | 1 |
| Philips Electronics North America Corporation | $14.96 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $572.42 | 18 |
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $19.26 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294407 | CMS |
| ABIOMED | $17.95 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294495 | CMS |
| ABIOMED | $145.19 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294507 | CMS |
| ABIOMED | $8.80 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294499 | CMS |
| ABIOMED | $8.10 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294501 | CMS |
| ABIOMED | $26.98 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294497 | CMS |
| ABIOMED | $132.99 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294411 | CMS |
| ABIOMED | $3.77 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294513 | CMS |
| ABIOMED | $15.86 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294537 | CMS |
| ABIOMED | $23.02 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142294525 | CMS |
| Chiesi USA, Inc. | $27.13 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151806611 | CMS |
| Chiesi USA, Inc. | $38.27 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151806616 | CMS |
| Grifols USA, LLC | $13.91 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124719304 | CMS |
| Grifols USA, LLC | $15.29 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124719300 | CMS |
| Grifols USA, LLC | $13.94 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124719302 | CMS |
| Kiniksa Pharmaceuticals International, plc | $18.87 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154895153 | CMS |
| La Jolla Pharmaceutical Company | $28.13 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154248226 | CMS |
| Philips North America LLC | $14.96 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146893503 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.